Page last updated: 2024-11-05

ethyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl acetate is a colorless liquid with a characteristic sweet smell. It is a common solvent used in many industries, including the production of paints, varnishes, and adhesives. Ethyl acetate is also used as a flavoring agent and as a solvent in the pharmaceutical industry. It is synthesized by the reaction of ethanol with acetic acid in the presence of a catalyst. Ethyl acetate is relatively non-toxic and biodegradable, making it a popular choice for many applications. It is studied for its applications as a solvent, its environmental impact, and its potential use in various chemical processes.'

ethyl acetate : The acetate ester formed between acetic acid and ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8857
CHEMBL ID14152
CHEBI ID27750
MeSH IDM0050978

Synonyms (181)

Synonym
ethylacetaat
ethylacetat
acoet
etoac
ethylazetat
essigsaeureethylester
ch3-co-o-ch3
1-acetoxyethane
CHEBI:27750 ,
acetic acid ethyl ester
C0036
acetoxyethane
essigester
acetidin
ethyl acetic ester
nsc-70930
wln: 2ov1
ethyle(acetate d')
etile(acetato di)
vinegar naphtha
nsc70930
acetic ether
aethylacetat
octan etylu
ethylacetaat [dutch]
ethylacetate ,
hsdb 83
aethylacetat [german]
einecs 205-500-4
acetato de etilo [spanish]
ai3-00404
ccris 6036
rcra waste no. u112
ethyl acetate (natural)
octan etylu [polish]
ethyle (acetate d') [french]
essigester [german]
nsc 70930
ethylester kyseliny octove [czech]
caswell no. 429
etile (acetato di) [italian]
fema no. 2414
epa pesticide chemical code 044003
rcra waste number u112
acetate d'ethyle [french]
un1173
acetic acid, ethyl ester
ethyl ethanoate
acetic acid,ethyl ester
inchi=1/c4h8o2/c1-3-6-4(2)5/h3h2,1-2h
NCGC00091766-01
acetyl ester
141-78-6
ethyl acetate
C00849
acetic ester
ethyl acetate, capillary gc grade, >=99.5%
ethyl acetate, natural, >=99%, fcc, fg
ethyl acetate, >=99%, fcc, fg
D02319
ethyl acetate (nf)
acet-eth-ester
acetic-acid-ethylester
acet-ethylester
ethyl acetate, reagentplus(r), >=99.8%
ethyl acetate, reagentplus(r), >=99.5%
ethyl acetate, anhydrous, 99.8%
A0030
e1504 ,
CHEMBL14152
FT-0693343
Q0040
AKOS000121947
A807811
tox21_202512
NCGC00260061-01
dtxcid602001
cas-141-78-6
dtxsid1022001 ,
tox21_111166
ch3cooc2h5
ethyl acetate, 99.9%
STL282717
etile (acetato di)
ethyl acetate [un1173] [flammable liquid]
ethyle (acetate d')
unii-76845o8nmz
76845o8nmz ,
ethyl acetate [nf]
acetate d'ethyle
acetato de etilo
ec 205-500-4
ethylester kyseliny octove
FT-0621744
ethyl acetate [inci]
ethyl acetate [who-dd]
ethyl acetate [hsdb]
ethyl acetate [mi]
ethyl acetate [fcc]
ethyl acetate [fhfi]
ethyl acetate [usp-rs]
ethyl acetate [ii]
ethyl acetate [mart.]
ethyl acetate [ep monograph]
EPITOPE ID:116868
etyl acetate
etylacetate
ethylactate
ethyl aceate
ehyl acetate
acetic acid ethylester
ethy acetate
ethylaceate
ch3co2ch2ch3
acetic ethyl ester
ehtyl acetate
ch3co2et
ethyl_acetate
2~ethyl acetate
ethyl actate
ethylacteate
et-oac
ch3co2c2h5
ethly acetate
ethyl-acetate
1-ethyl acetate
ethanol acetate
ethyl acteate
ethl acetate
acetic acid ethyl
un 1173
ethyl ester of acetic acid
mfcd00009171
ethyl acetate, hplc grade
ethyl acetate, environmental grade
ethyl acetate, spectrophotometric grade
bdbm50128823
J-521240
ethyl acetate hplc grade
ethyl acetate, acs grade
F0001-0489
ethyl acetate, saj first grade, >=99.0%
ethyl acetate, united states pharmacopeia (usp) reference standard
ethyl acetate, puriss., meets analytical specification of ph. eur., bp, nf, >=99.5% (gc)
ethyl acetate, laboratory reagent, >=99.0% (gc)
ethyl acetate, for hplc, >=99.8% (gc)
ethyl acetate, biotech. grade, >=99.8%
ethyl acetate, analytical standard
ethyl acetate, puriss. p.a., acs reagent, >=99.5% (gc)
ethyl acetate, puriss. p.a., free of higher boiling impurities, >=99.9% (gc)
ethyl acetate, for hplc
ethyl acetate, tested according to ph.eur.
ethyl acetate, for hplc, >=99.7%
ethyl acetate, >=99.5%
ethyl acetate, hplc grade, 99.8%
ethyl acetate, acs reagent, >=99.5%
ethyl acetate, puriss. p.a., acs reagent, reag. iso, reag. ph. eur., >=99.5% (gc)
ethyl acetate, jis special grade, >=99.5%
ethyl acetate, for hplc, >=99.8%
ethyl acetate, pra grade, >=99.5%
ethyl acetate, for hplc, >=99.5%
ethyl acetate, acs reagent
ethyl acetate, lr, >=99%
ethyl acetate, pharmaceutical secondary standard; certified reference material
ethyl acetate, uv-ir min. 99.8%, isocratic grade
ethyl acetate, ar, >=99%
ethyl acetate; ethyl ethanoate
J-007556
ethyl acetate, hplc
ethyl acetate (1-13c)
Q407153
ethylacetate, pure, meets the analytical specifications of ph. eur.
ethyl acetate 100 microg/ml in acetonitrile
ethyl acetate 100ml
ethyl acetate (2-13c)
ethyl acetate, 99.9% low benzene
EN300-31487
ethyl acetate (ep monograph)
ethyl acetate (mart.)
caswell no 429
ethyl acetate (ii)

Research Excerpts

Overview

Ethyl acetate (EA) is an ordinary organic compound in fruits, wine and cosmetics, and used as a solvent frequently. EA appears to be a satisfactory subsitute solvent for diethyl ether in the Formalin-ether sedimentation technique.

ExcerptReferenceRelevance
"Ethyl acetate is an important flavor element that is a vital component of "( Dynamic Transcriptome Analysis Reveals Transcription Factors Involved in the Synthesis of Ethyl Acetate in Aroma-Producing Yeast.
Du, B; Ifrah, K; Li, W; Li, X; Ni, B; Xu, Y; Zhang, C, 2022
)
2.39
"Ethyl acetate is an important organic solvent and currently produced from fossil carbon resources. "( Utilization of delactosed whey permeate for the synthesis of ethyl acetate with Kluyveromyces marxianus.
Franz, A; Hoffmann, A; Löser, C; Walther, T, 2023
)
2.59
"Ethyl acetate is an important chemical raw material and solvent. "( Inherent Ethyl Acetate Selectivity in a Trianglimine Molecular Solid.
Chen, L; Chong, SY; Clowes, R; Cooper, AI; Day, GM; He, D; Little, MA; Liu, M; McKie, K; Roper, MG; Zhao, C, 2021
)
2.48
"Ethyl acetate is an industrially relevant ester that is currently produced exclusively through unsustainable processes. "( Ethyl acetate production by the elusive alcohol acetyltransferase from yeast.
Ellena, V; Garcés Daza, F; Kengen, SWM; Kruis, AJ; Levisson, M; Mars, AE; van der Oost, J; van der Ploeg, M; Weusthuis, RA, 2017
)
3.34
"Ethyl acetate is an environmentally friendly solvent with many industrial applications. "( Perspectives for the biotechnological production of ethyl acetate by yeasts.
Bley, T; Löser, C; Urit, T, 2014
)
2.1
"Ethyl acetate (EA) is an ordinary organic compound in fruits, wine and cosmetics, and used as a solvent frequently. "( The anti-inflammatory effects of ethyl acetate on Lipopolysaccharide/D-galactosamine challenged mice and Lipopolysaccharide activated RAW264.7 cells.
Cao, X; Li, J; Liu, T; Liu, Y; Liu, Z; Wang, Y; Wilson, B; Xiao, N, 2012
)
2.1
"Ethyl acetate appears to be a satisfactory subsitute solvent for diethyl ether in the Formalin-ether sedimentation technique. "( Ethyl acetate as a substitute for diethyl ether in the formalin-ether sedimentation technique.
Bullock, SL; Melvin, DM; Spruill, CL; Young, KH, 1979
)
3.15

Effects

Ethyl acetate has attracted much attention as an important chemical raw material and a flavor component of alcoholic beverages. The extract has the strongest cytotoxic effect with an IC50 of 18.5 μg/ml. Ethyl acetates can also enhance melanogenesis and tyrosinase activity of B16-F0 melanoma cells.

ExcerptReferenceRelevance
"The ethyl acetate fraction has the highest ability for cytotoxicity on the liver and cell line at a concentration of 200 μg mL<sup>1</sup> through MTT."( Identification, Phytochemistry and Biological Activities of
Bach, TS; Cuong, CB; Khoi, TX; La, VH; Nguyen, DH; Nguyen, TV, 2023
)
1.39
"Ethyl acetate has attracted much attention as an important chemical raw material and a flavor component of alcoholic beverages. "( Increase ethyl acetate production in Saccharomyces cerevisiae by genetic engineering of ethyl acetate metabolic pathway.
Dong, J; Dong, S; Fu, X; Li, X; Wang, P; Xiao, D, 2019
)
2.37
"Ethyl acetate extract has the strongest cytotoxic effect with an IC50 of 18.5 μg/ml."( In vitro antileukaemic activity of extracts from Daphne gnidium leaves against sensitive and multidrug resistant K562/R7 cells.
Chaabane, F; Chekir-Ghedira, L; Dijoux-Franca, MG; Dumontet, C; Ghedira, K; Krifa, M; Loussaeif, A; Matera, E, 2014
)
1.12
"Its ethyl acetate extract has shown potent in vitro antioxidant activity and found to contain 7.26% of a bitter secoiridoid glycoside, swertiamarin."( Antioxidant and hepatoprotective effect of the ethyl acetate extract of Enicostemma axillare (Lam). Raynal against CCL4-induced liver injury in rats.
Badami, S; Jaishree, V; Krishnamurthy, PT, 2010
)
1.1
"Ethyl acetate extract has also the ability to enhance melanogenesis and tyrosinase activity of B16-F0 melanoma cells."( Phytochemical potential of Daphne gnidium in inhibiting growth of melanoma cells and enhancing melanogenesis of B16-F0 melanoma.
Chaabane, F; Chekir-Ghedira, L; Ghedira, K; Pinon, A; Simon, A, 2013
)
1.11
"Ethyl acetate has recently been shown to be a comparable substitute."( Clinical comparison of ethyl acetate and diethyl ether in the formalin-ether sedimentation technique.
Erdman, DD, 1981
)
1.29

Treatment

ExcerptReferenceRelevance
"Pretreatment of ethyl acetate extract of Phellinus rimosus (Berk) Pilat protected cisplatin induced nephrotoxicity in mice. "( Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.
Ajith, TA; Janardhanan, KK; Jose, N, 2002
)
0.9

Toxicity

ExcerptReferenceRelevance
" The calculated LD50 after oral and intraperitoneal administration was 345."( Neuromuscular effects and acute toxicity of an ethyl acetate extract of Spigelia anthelmia Linn.
Bevilaqua, CM; Camurça-Vasconcelos, AL; Melo, LM; Morais, SM; Nascimento, NR; Rocha, MF; Sousa, CM, 2004
)
0.58
" The LD50 of the sample II was 82."( [Compared studies on the effect and toxicity of extractions of Fructus Meliae Toosendan in mice].
Cheng, L; Huang, L; Lei, Y; Liang, YY; Tan, ZH; Tang, DX, 2007
)
0.34
"To evaluate the anti-inflammatory effects of hydroethanolic root extract of Jacaranda decurrens in rats and to determine the safe of this plant after acute exposure."( Anti-inflammatory effects and acute toxicity of hydroethanolic extract of Jacaranda decurrens roots in adult male rats.
Arena, AC; Arruda, A; Cardoso, CA; Kassuya, CA; Santos, JA; Silva, MA; Vieira, Mdo C, 2012
)
0.38
" General behavior and toxic symptoms were observed for 14 days."( Anti-inflammatory effects and acute toxicity of hydroethanolic extract of Jacaranda decurrens roots in adult male rats.
Arena, AC; Arruda, A; Cardoso, CA; Kassuya, CA; Santos, JA; Silva, MA; Vieira, Mdo C, 2012
)
0.38
" In the present study we therefore assayed the acute toxicity to larval fish, of a whole acidified OSPW extract and an esterifiable naphthenic acids fraction, de-esterified with alkali: both fractions were toxic (LC50 ∼5-8mgL(-1))."( Acute toxicity of aromatic and non-aromatic fractions of naphthenic acids extracted from oil sands process-affected water to larval zebrafish.
Frank, RA; Henry, TB; Hewitt, LM; Reinardy, HC; Rowland, SJ; Scarlett, AG; West, CE, 2013
)
0.39
"No animals died and no toxic changes were observed in clinical signs, body weight, and organ weight."( Acute oral toxicity of the ethyl acetate fraction of Orostachys japonicus in mice.
Kim, SH; Kwon, JH; Lee, DS; Lee, HS; Ryu, DS; Shin, HR, 2014
)
0.7
" The dietaryexposures calculated against the average concentrations detected were wellbelow the maximum permissible intake (MPI) values and the collected raisin samples were considered safe for human consumption without any acute toxicity hazard."( Targeted screening and safety evaluation of 276 agrochemical residues in raisins using buffered ethyl acetate extraction and liquid chromatography-tandem mass spectrometry analysis.
Banerjee, K; Bhongale, A; Girame, R; Hingmire, S; Jadhav, M; Pudale, A; Shabeer, TPA, 2017
)
0.67
" Both EGY6 and EGY8 caused the highest significant reduction in the levels of packed cell volume (PCV), red blood cell count (RBC), and hemoglobin (Hb), which indicate that these Pseudomonas strain metabolites could cause anemia and toxic effects on hematological values in animals that were infected with them."( In Vivo Evaluation of the Toxic Effect of Ethyl Acetate Extracts of Marine Antibiotic Resistance Pseudomonas Species Derived from the Red Sea.
Abozinadah, NY; Al-Zahrani, HAA; El-Bondkly, AMA; El-Gendy, MMAA, 2018
)
0.75
"Recent concerns about the possible adverse effects of agricultural chemicals on health and environment have generated a considerable interest in biological alternatives."( Evaluation of genotoxic and cytotoxic effects of ethyl acetate extract of Aspergillus flavus on Spodoptera litura.
Chadha, P; Kaur, A; Kaur, M; Kaur, R; Kaur, S; Yadav, AK, 2019
)
0.77
" Furthermore, DNA repair studies predicted the longevity of toxic effects induced by fungus."( Evaluation of genotoxic and cytotoxic effects of ethyl acetate extract of Aspergillus flavus on Spodoptera litura.
Chadha, P; Kaur, A; Kaur, M; Kaur, R; Kaur, S; Yadav, AK, 2019
)
0.77
"Cisplatin (CisPT) is a chemotherapeutic drug that outcomes in adverse effects."( Acacia hydaspica R. Parker ethyl-acetate extract abrogates cisplatin-induced nephrotoxicity by targeting ROS and inflammatory cytokines.
Afsar, T; Al Kheraif, AA; Aldisi, D; Almajwal, A; Arshad, M; Razak, S; Shabbir, M, 2021
)
0.62
"Cisplatin (CisPT) is a chemotherapeutic that outcome in adverse effects including neurotoxicity."( Reversal of cisplatin triggered neurotoxicity by Acacia hydaspica ethyl acetate fraction via regulating brain acetylcholinesterase activity, DNA damage, and pro-inflammatory cytokines in the rodent model.
Afsar, T; Almajwal, A; Razak, S, 2022
)
0.96
" However, the basis of these toxic substances and the mechanism of neurotoxicity remain unclear."( Neurotoxicity study of ethyl acetate extract of Zanthoxylum armatum DC. on SH-SY5Y based on ROS mediated mitochondrial apoptosis pathway.
Chen, Y; Guo, J; Hu, T; Huang, Y; Qiuyan, L; Rao, C; Wen, J; Xiang, Q; Yang, N; Zhang, J, 2024
)
1.75
"To evaluate the effects of ZADC on nerve cells and their damage mechanisms and discuss the possible toxic substance basis."( Neurotoxicity study of ethyl acetate extract of Zanthoxylum armatum DC. on SH-SY5Y based on ROS mediated mitochondrial apoptosis pathway.
Chen, Y; Guo, J; Hu, T; Huang, Y; Qiuyan, L; Rao, C; Wen, J; Xiang, Q; Yang, N; Zhang, J, 2024
)
1.75

Pharmacokinetics

ExcerptReferenceRelevance
" This model, developed by simplification of existing physiologically based pharmacokinetic (PBPK) nasal models, has three tissue regions in two flow paths."( Dosimetric adjustment factors for methyl methacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model.
Andersen, ME; Frederick, CB; Kimbell, JS; Sarangapani, R, 1999
)
0.3
" In conclusion, the validation results showed that this method was sensitive, economical and less toxic and it can successfully fulfill the requirement of clinical pharmacokinetic study of domperidone oral preparation in Chinese healthy volunteers."( Determination of domperidone in human plasma using liquid chromatography coupled to tandem mass spectrometry and its pharmacokinetic study.
Chen, K; Guo, R; Liu, S; Liu, X; Teng, Y; Wang, B; Wei, C; Yuan, G; Zhang, D; Zhang, J; Zhang, R, 2012
)
0.38
" The findings indicate that the assay method is suitable for routine pharmacokinetic (PK) studies of FK-3000 in rats."( Development of a LC-MS method for quantification of FK-3000 and its application to in vivo pharmacokinetic study in drug development.
Ahn, SH; Chae, YJ; Cho, SC; Jin, QR; Kwon, SW; Lee, GW; Lee, JH; Lee, KR; Park, DH; Seo, JW; Woo, YA, 2012
)
0.38
" The method was successfully applied to human pharmacokinetic study of urapidil and aripiprazole in healthy human male volunteers."( Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study.
Ambavaram, VB; Gajulapalle, M; Kalluru, GR; Nandigam, V; Vemula, M, 2013
)
0.39
" The method herein described was superior to previous methods and was successfully applied to the pharmacokinetic study of KTZ in healthy Chinese volunteers after oral administration."( Quantitative determination of ketoconazole by UPLC-MS/MS in human plasma and its application to pharmacokinetic study.
Hu, ML; Xu, M; Ye, Q, 2014
)
0.4
" The method was successfully used to investigate the pharmacokinetic profile of CTX after oral (100 mg/kg) and intravenous (25 mg/kg) administration in rats."( Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
Fan, J; Feng, F; Guan, L; Kou, Z; Liu, W; Zhang, Y, 2014
)
0.4
"In order to evaluate the pharmacokinetic characteristics of a new formulation of a bifendate solid dispersion in beagle dogs, a novel, sensitive and rapid supercritical fluid chromatography-tandem mass spectrometry (SFC-MS/MS) method was established and validated."( Preclinical pharmacokinetic evaluation of a new formulation of a bifendate solid dispersion using a supercritical fluid chromatography-tandem mass spectrometry method.
Liu, M; Ma, J; Wang, X; Yang, D; Zhang, T; Zhao, L, 2014
)
0.4
" The developed method was successfully applied to the pharmacokinetic study of ZW14 in beagle dogs after oral and intravenous administration of 2 mg/kg."( A rapid and sensitive HPLC-MS/MS method for determination of an aminopyridazine derived anti-neuroinflammatory agent (ZW14) in dog plasma: Application to a pharmacokinetic study.
Deng, J; Guo, J; Liang, F; Liu, P; Lv, B; Tang, J; Xie, H, 2015
)
0.42
"A physiologically based pharmacokinetic (PBPK) model was developed and applied to a metabolic series approach for the ethyl series (i."( Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans.
Creim, JA; Crowell, SR; Faber, W; Smith, JN; Teeguarden, JG, 2015
)
0.67
" This novel method has been applied to a pharmacokinetic study in rats."( Highly Sensitive LC-MS-MS Method for the Determination of Tacrine in Rat Plasma: Application to Pharmacokinetic Studies in Rats.
Mullangi, R; Ponnayyan Sulochana, S; Ravichandiran, V; Sukumaran, SK, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
"In this paper, a high-performance thin-layer chromatography (HPTLC) method combined with densitometry has been described."( Quantitative analysis of phenobarbital in dosage form by thin-layer chromatography combined with densitometry.
Kryska, M; Matysik, G; Skalska, A; Wójciak-Kosior, M,
)
0.13
"To study the safety and potential health benefits of soy isoflavones, a rapid and simple method based on liquid chromatography combined with mass spectrometry (LC/MS) and photodiode array detector (PDA) was developed for the determination of isoflavones in rat plasma."( An accurate and reproducible method for the quantitative analysis of isoflavones and their metabolites in rat plasma using liquid chromatography/mass spectrometry combined with photodiode array detection.
Cooke, G; Gilani, GS; Lau, BP; Robertson, P; Sepehr, E,
)
0.13
" stolonifera and their antioxidant and anti-inflammatory effects in combination with network pharmacology and molecular docking."( [Anti-inflammatory material basis and mechanism of Artemisia stolonifera based on UPLC-Q-TOF-MS combined with network pharmacology and molecular docking].
Chen, L; DU, HZ; Guo, CW; Kang, LP; Li, SG; Liu, DH; Wang, YQ; Zhu, YY, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" The administration of these substances to animals is usually made through an intra-muscular pathway with the steroid under its ester form for a higher bioavailability and a longer lasting effect."( Ultra high performance liquid chromatography/tandem mass spectrometry based identification of steroid esters in serum and plasma: an efficient strategy to detect natural steroids abuse in breeding and racing animals.
Bichon, E; Bonnaire, Y; Cesbron, N; Dervilly-Pinel, G; Hanganu, F; Kaabia, Z; Le Bizec, B; Popot, MA, 2013
)
0.39
"Pomelo fruit juice and pomelo ethylacetate extract have been shown to increase the bioavailability of some CYP3A substrates."( The effect of pomelo mix ethyl acetate extract on CYP3A6 and P-glycoprotein gene transcripts in rabbits.
Al-Antary, ET; Al-Embideen, SN; Amireh, AO; Irshaid, YM; Zihlef, MA; Zmaily, MG; Zmeili, SM, 2014
)
0.71
" CTX showed rapid excretion and low bioavailability in rats."( Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
Fan, J; Feng, F; Guan, L; Kou, Z; Liu, W; Zhang, Y, 2014
)
0.4
" Salivary and plasma proteins may bind (co)monomers and additives and may thereby contribute to a lower bioavailability of leachables from RBCs in vivo than previously thought."( Release and protein binding of components from resin based composites in native saliva and other extraction media.
Carell, T; Geurtsen, W; Hellwig, E; Hickel, R; Högg, C; Reichl, FX; Rothmund, L; Schweikl, H; Shehata, M; Van Landuyt, KL, 2015
)
0.42
" The oral bioavailability of ZW14 was 26."( A rapid and sensitive HPLC-MS/MS method for determination of an aminopyridazine derived anti-neuroinflammatory agent (ZW14) in dog plasma: Application to a pharmacokinetic study.
Deng, J; Guo, J; Liang, F; Liu, P; Lv, B; Tang, J; Xie, H, 2015
)
0.42
" The respiratory bioavailability of ethyl acetate and ethanol were estimated from closed chamber inhalation studies and measured ventilation rates."( Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans.
Creim, JA; Crowell, SR; Faber, W; Smith, JN; Teeguarden, JG, 2015
)
0.95
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Dose-response curves for three odorants were carried out for comparing olfaction in either complete animals or flies surgically deprived of antennae. Investigations revealed 10mg/ml dosage of crude extract was the most efficacious dose. Among the fractions the ethyl acetate fraction showed the most anthelmintic property.

ExcerptRelevanceReference
" The elevation in aneuploidy frequency induced by high doses of these compounds was reduced in a dose-response manner in the presence of increasing concentrations of dimethyl sulfoxide."( Aneuploidy induced by nocodazole or ethyl acetate is suppressed by dimethyl sulfoxide.
Goin, CJ; Mayer, VW, 1987
)
0.55
" Dose-response curves for three odorants: ethyl acetate, propionaldehyde and benzaldehyde were carried out for comparing olfaction in either complete animals or flies surgically deprived of antennae."( Quantifying relative importance of maxillary palp information on the olfactory behavior of Drosophila melanogaster.
Alcorta, E; Charro, MJ, 1994
)
0.55
" The aim of this study is: a) to investigate the antimicrobial activity of crude honey, b) to separate the fractions responsible for its activity, c) to formulate the honey extract as semisolid dosage forms, d) to study its release, and e) to determine its stability."( Honey, a prospective antibiotic: extraction, formulation, and stability.
el-Shattawy, HH; Ibrahim, EA; Kassem, AA; Khan, MA; Reddy, IK; Zaghloul, AA, 2001
)
0.31
" These patients received a maximum dosage of 180 mg/day."( A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
Cush, JJ; Garret, M; Lipsky, PE; Tao, X, 2001
)
0.64
" The haemoglobin, haematocrit, and RBC count in the study population had a significant dose-response relation with air 2-EEA levels."( Haematological effects among silk screening workers exposed to 2-ethoxy ethyl acetate.
Chen, CY; Hsieh, AT; Liao, GD; Lin, YC; Liou, SH; Loh, CH; Shih, TS, 2003
)
0.55
" The assay was applied to a pharmacokinetic study in mice to determine dosing schedules that would approximate therapeutic ZD6474 levels determined in humans."( Rapid and sensitive LC/MS/MS analysis of the novel tyrosine kinase inhibitor ZD6474 in mouse plasma and tissues.
Bradshaw, EL; Gustafson, DL; Long, ME; Zirrolli, JA, 2005
)
0.33
" Depending on dosage (0."( A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Doerge, DR; Helferich, WG; Ju, YH, 2008
)
0.35
" The 50% cytotoxic concentration (CC(50)) was determined by the dose-response curve."( Induction of non-apoptotic cell death by Odontioda Marie Noel 'Velano' extracts in human oral squamous cell carcinoma cell lines.
Masuda, Y; Sakagami, H; Shirataki, Y; Suzuki, R; Ueda, JY; Umemura, N,
)
0.13
" The 50% cytotoxic concentration (CC(50)) was determined from the dose-response curve."( Induction of non-apoptotic cell death in human oral squamous cell carcinoma cell lines by Rhinacanthus nasutus extract.
Horii, H; Sakagami, H; Shirataki, Y; Suzuki, R; Ueda, JY; Umemura, N,
)
0.13
" And 40 compounds were detected in dosed rat plasma sample, including 16 prototypes and 24 metabolites underwent metabolic process of glucuronidation, glucosylation, sulfation, methylation, hydroxylation, dehydrogenation or mixed modes."( Chemical fingerprint and metabolic profile analysis of ethyl acetate fraction of Gastrodia elata by ultra performance liquid chromatography/quadrupole-time of flight mass spectrometry.
Cheng, M; Liu, X; Tang, C; Wang, L; Xiao, H, 2016
)
0.68
" The research indicated that removal rates of single-component toluene, ethyl acetate and acetone were 57%, 62% and 58% respectively under conditions of 400 mg · m⁻³ initial concentration, 120 mm illumination distance, 1 g/350 cm² dosage of CoCuMnOx and 6 h of irradiation time by 100 W tungsten halogen lamp."( [CoCuMnOx Photocatalyzed Oxidation of Multi-component VOCs and Kinetic Analysis].
Bo, LL; Feng, QQ; Gao, B; Liu, JD; Meng, HL; Tan, N; Xie, S, 2016
)
0.67
" High dosage (200 μg/mL) of EEVt displayed highly significant inhibitory (p < 0."( The anti-inflammatory and analgesic activities of the ethyl acetate extract of Viburnum taitoense Hayata.
He, S; Huang, Y; Qiu, L; Wu, X; Xie, J; Xie, Y; Xu, H; Zhang, Q; Zou, L, 2021
)
0.87
" Investigations revealed 10mg/ml dosage of crude extract was the most efficacious dose and amongst the fractions the ethyl acetate fraction showed the most anthelmintic property."( Anthelmintic efficacy of Holarrhena pubescens against Raillietina spp. of domestic fowl through ultrastructural, histochemical, biochemical and GLCM analysis.
Gupta, M; Kar, PK; Majumdar, R; Saha, R; Saha, S, 2023
)
1.12
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
polar aprotic solventA solvent with a comparatively high relative permittivity (or dielectric constant), greater than ca. 15, and a sizable permanent dipole moment, that cannot donate suitably labile hydrogen atoms to form strong hydrogen bonds.
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitorAn EC 3.4.19.* (omega-peptidase) inhibitor that interferes with the action of pyroglutamyl-peptidase I (EC 3.4.19.3).
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency35.71680.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency35.71680.025120.237639.8107AID886; AID893
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
glp-1 receptor, partialHomo sapiens (human)Potency3.54810.01846.806014.1254AID624172
pregnane X receptorRattus norvegicus (Norway rat)Potency79.43280.025127.9203501.1870AID651751
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency35.48130.011212.4002100.0000AID1030
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.68320.000214.376460.0339AID720691
lamin isoform A-delta10Homo sapiens (human)Potency0.14130.891312.067628.1838AID1487
Cellular tumor antigen p53Homo sapiens (human)Potency68.93850.002319.595674.0614AID651631
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency68.93850.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency68.93850.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Procathepsin LHomo sapiens (human)IC50 (µMol)10.00000.00021.66619.5100AID1253921
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)IC50 (µMol)10.00000.00040.16800.9772AID1253921
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (162)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
adaptive immune responseProcathepsin LHomo sapiens (human)
proteolysisProcathepsin LHomo sapiens (human)
protein autoprocessingProcathepsin LHomo sapiens (human)
fusion of virus membrane with host plasma membraneProcathepsin LHomo sapiens (human)
receptor-mediated endocytosis of virus by host cellProcathepsin LHomo sapiens (human)
antigen processing and presentationProcathepsin LHomo sapiens (human)
antigen processing and presentation of exogenous peptide antigen via MHC class IIProcathepsin LHomo sapiens (human)
collagen catabolic processProcathepsin LHomo sapiens (human)
zymogen activationProcathepsin LHomo sapiens (human)
enkephalin processingProcathepsin LHomo sapiens (human)
fusion of virus membrane with host endosome membraneProcathepsin LHomo sapiens (human)
CD4-positive, alpha-beta T cell lineage commitmentProcathepsin LHomo sapiens (human)
symbiont entry into host cellProcathepsin LHomo sapiens (human)
antigen processing and presentation of peptide antigenProcathepsin LHomo sapiens (human)
proteolysis involved in protein catabolic processProcathepsin LHomo sapiens (human)
elastin catabolic processProcathepsin LHomo sapiens (human)
macrophage apoptotic processProcathepsin LHomo sapiens (human)
cellular response to thyroid hormone stimulusProcathepsin LHomo sapiens (human)
positive regulation of apoptotic signaling pathwayProcathepsin LHomo sapiens (human)
positive regulation of peptidase activityProcathepsin LHomo sapiens (human)
immune responseProcathepsin LHomo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (48)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
fibronectin bindingProcathepsin LHomo sapiens (human)
cysteine-type endopeptidase activityProcathepsin LHomo sapiens (human)
protein bindingProcathepsin LHomo sapiens (human)
collagen bindingProcathepsin LHomo sapiens (human)
cysteine-type peptidase activityProcathepsin LHomo sapiens (human)
histone bindingProcathepsin LHomo sapiens (human)
proteoglycan bindingProcathepsin LHomo sapiens (human)
serpin family protein bindingProcathepsin LHomo sapiens (human)
cysteine-type endopeptidase activator activity involved in apoptotic processProcathepsin LHomo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (39)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
extracellular regionProcathepsin LHomo sapiens (human)
extracellular spaceProcathepsin LHomo sapiens (human)
nucleusProcathepsin LHomo sapiens (human)
lysosomeProcathepsin LHomo sapiens (human)
multivesicular bodyProcathepsin LHomo sapiens (human)
Golgi apparatusProcathepsin LHomo sapiens (human)
plasma membraneProcathepsin LHomo sapiens (human)
apical plasma membraneProcathepsin LHomo sapiens (human)
endolysosome lumenProcathepsin LHomo sapiens (human)
chromaffin granuleProcathepsin LHomo sapiens (human)
lysosomal lumenProcathepsin LHomo sapiens (human)
intracellular membrane-bounded organelleProcathepsin LHomo sapiens (human)
collagen-containing extracellular matrixProcathepsin LHomo sapiens (human)
extracellular exosomeProcathepsin LHomo sapiens (human)
endocytic vesicle lumenProcathepsin LHomo sapiens (human)
extracellular spaceProcathepsin LHomo sapiens (human)
lysosomeProcathepsin LHomo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID15289Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Effects of volume and surface property in hydrolysis by acetylcholinesterase. The trimethyl site.
AID17473Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Effects of volume and surface property in hydrolysis by acetylcholinesterase. The trimethyl site.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID343684Alkane-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID28486Second-order rate constant (M-1 s-1) for the alkaline hydrolysis in water at 30 degrees C2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Acylating agents as enzyme inhibitors and understanding their reactivity for drug design.
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1253922Inhibition of human liver cathepsin B using Z-RR-AMC as substrate after 5 mins by fluorescence assay2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID229782Ratio of Kcat to Km was reported.1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Effects of volume and surface property in hydrolysis by acetylcholinesterase. The trimethyl site.
AID1253921Inhibition of human liver cathepsin L using Z-FR-AMC as substrate measured every 15 sec for 5 mins by fluorescence assay2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1145366Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID167125Eye irritation potential accessed using Draize in vivo rabbit eye irritation test2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1102969Antimicrobial activity against Bacillus cereus ATCC 11778 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID343683Octanol-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1102814Antimicrobial activity against Escherichia coli O157:H7 ATCC 43894 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID18079Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant, (Km) an apparent dissociation constant, and related to the enzyme's affinity for the substrate was reported.1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Effects of volume and surface property in hydrolysis by acetylcholinesterase. The trimethyl site.
AID1253927Inhibition of human liver cathepsin L at 5%/v using Z-FR-AMC as substrate measured every 15 sec for 5 mins by fluorescence assay2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
AID1682590Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Cytotoxic components from the leaves of Erythrophleum fordii induce human acute leukemia cell apoptosis through caspase 3 activation and PARP cleavage.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID1682589Cytotoxicity against human KG-1 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Cytotoxic components from the leaves of Erythrophleum fordii induce human acute leukemia cell apoptosis through caspase 3 activation and PARP cleavage.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1102938Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1372697Inhibition of mushroom tyrosinase using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID1102876Antimicrobial activity against Listeria monocytogenes ATCC 19111 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102845Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1102907Antimicrobial activity against Vibrio parahaemolyticus ATCC 33844 assessed as growth inhibition rate at 1.44 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,926)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990107 (5.56)18.7374
1990's133 (6.91)18.2507
2000's448 (23.26)29.6817
2010's905 (46.99)24.3611
2020's333 (17.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 112.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index112.63 (24.57)
Research Supply Index7.61 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index209.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (112.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (0.25%)5.53%
Reviews8 (0.40%)6.00%
Case Studies4 (0.20%)4.05%
Observational0 (0.00%)0.25%
Other2,003 (99.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]